Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Inventory Average (2016 - 2025)

Historic Inventory Average for Amicus Therapeutics (FOLD) over the last 10 years, with Q3 2025 value amounting to $166.4 million.

  • Amicus Therapeutics' Inventory Average rose 6922.93% to $166.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.4 million, marking a year-over-year increase of 6922.93%. This contributed to the annual value of $89.2 million for FY2024, which is 11371.54% up from last year.
  • Amicus Therapeutics' Inventory Average amounted to $166.4 million in Q3 2025, which was up 6922.93% from $143.6 million recorded in Q2 2025.
  • Amicus Therapeutics' 5-year Inventory Average high stood at $166.4 million for Q3 2025, and its period low was $17.1 million during Q3 2022.
  • Moreover, its 5-year median value for Inventory Average was $39.2 million (2023), whereas its average is $59.5 million.
  • As far as peak fluctuations go, Amicus Therapeutics' Inventory Average crashed by 2601.28% in 2022, and later skyrocketed by 21717.08% in 2023.
  • Over the past 5 years, Amicus Therapeutics' Inventory Average (Quarter) stood at $24.4 million in 2021, then decreased by 24.14% to $18.5 million in 2022, then surged by 214.47% to $58.3 million in 2023, then skyrocketed by 100.73% to $117.1 million in 2024, then skyrocketed by 42.15% to $166.4 million in 2025.
  • Its Inventory Average was $166.4 million in Q3 2025, compared to $143.6 million in Q2 2025 and $125.6 million in Q1 2025.